Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-MYO-RARE: Multimodal Imaging in Rare Cardiomyopathy
NCT06794710Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Feb 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Renji Hospital. Primary endpoint: The Heart Failure Incidence of Rare cardiomyopathy at 24 months. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06794710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794710.